These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 38760690)

  • 21. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential.
    Suvarna K; Biswas D; Pai MGJ; Acharjee A; Bankar R; Palanivel V; Salkar A; Verma A; Mukherjee A; Choudhury M; Ghantasala S; Ghosh S; Singh A; Banerjee A; Badaya A; Bihani S; Loya G; Mantri K; Burli A; Roy J; Srivastava A; Agrawal S; Shrivastav O; Shastri J; Srivastava S
    Front Physiol; 2021; 12():652799. PubMed ID: 33995121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning-based prediction of delirium 24 h after pediatric intensive care unit admission in critically ill children: A prospective cohort study.
    Lei L; Zhang S; Yang L; Yang C; Liu Z; Xu H; Su S; Wan X; Xu M
    Int J Nurs Stud; 2023 Oct; 146():104565. PubMed ID: 37542959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
    Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
    PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and chronic obstructive pulmonary disease.
    Zhang Z; Lin F; Liu F; Li Q; Li Y; Zhu Z; Guo H; Liu L; Liu X; Liu W; Fang Y; Wei X; Lu W
    Int J Infect Dis; 2022 Mar; 116():258-267. PubMed ID: 35017110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Interpretable Machine Learning Model for Accurate Prediction of Sepsis in the ICU.
    Nemati S; Holder A; Razmi F; Stanley MD; Clifford GD; Buchman TG
    Crit Care Med; 2018 Apr; 46(4):547-553. PubMed ID: 29286945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units.
    Kugler S; Hahnefeld L; Kloka JA; Ginzel S; Nürenberg-Goloub E; Zinn S; Vehreschild MJ; Zacharowski K; Lindau S; Ullrich E; Burmeister J; Kohlhammer J; Schwäble J; Gurke R; Dorochow E; Bennett A; Dauth S; Campe J; Knape T; Laux V; Kannt A; Köhm M; Geisslinger G; Resch E; Behrens F
    Talanta; 2024 Feb; 268(Pt 1):125295. PubMed ID: 37866305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.
    Molano Franco D; Arevalo-Rodriguez I; Roqué I Figuls M; Montero Oleas NG; Nuvials X; Zamora J
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011811. PubMed ID: 31038735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validating a Proteomic Signature of Severe COVID-19.
    Cosgriff CV; Miano TA; Mathew D; Huang AC; Giannini HM; Kuri-Cervantes L; Pampena MB; Ittner CAG; Weisman AR; Agyekum RS; Dunn TG; Oniyide O; Turner AP; D'Andrea K; Adamski S; Greenplate AR; Anderson BJ; Harhay MO; Jones TK; Reilly JP; Mangalmurti NS; Shashaty MGS; Betts MR; Wherry EJ; Meyer NJ
    Crit Care Explor; 2022 Dec; 4(12):e0800. PubMed ID: 36479446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cell injury with inflammatory cytokine and coagulation in patients with sepsis.
    Ding H; Cao XY; Ma XG; Zhou WJ
    World J Emerg Med; 2013; 4(4):285-9. PubMed ID: 25215134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Anticoagulation Treatment in COVID-19 Patient Subgroups Identified by Clinical-Based Stratification and Unsupervised Machine Learning: A Matched Cohort Study.
    Bian Y; Le Y; Du H; Chen J; Zhang P; He Z; Wang Y; Yu S; Fang Y; Yu G; Ling J; Feng Y; Wei S; Huang J; Xiao L; Zheng Y; Yu Z; Li S
    Front Med (Lausanne); 2021; 8():786414. PubMed ID: 35004751
    [No Abstract]   [Full Text] [Related]  

  • 32. Machine-learning-based COVID-19 mortality prediction model and identification of patients at low and high risk of dying.
    Banoei MM; Dinparastisaleh R; Zadeh AV; Mirsaeidi M
    Crit Care; 2021 Sep; 25(1):328. PubMed ID: 34496940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of machine-learning models to accurately predict the risk for critical COVID-19.
    Assaf D; Gutman Y; Neuman Y; Segal G; Amit S; Gefen-Halevi S; Shilo N; Epstein A; Mor-Cohen R; Biber A; Rahav G; Levy I; Tirosh A
    Intern Emerg Med; 2020 Nov; 15(8):1435-1443. PubMed ID: 32812204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput proteomics of breast cancer subtypes: Biological characterization and multiple candidate biomarker panels to patients' stratification.
    Azevedo ALK; Gomig THB; Batista M; Marchini FK; Spautz CC; Rabinovich I; Sebastião APM; Oliveira JC; Gradia DF; Cavalli IJ; Ribeiro EMSF
    J Proteomics; 2023 Aug; 285():104955. PubMed ID: 37390896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic profiling of bronchoalveolar lavage fluid in critically ill patients with ventilator-associated pneumonia.
    Nguyen EV; Gharib SA; Palazzo SJ; Chow YH; Goodlett DR; Schnapp LM
    PLoS One; 2013; 8(3):e58782. PubMed ID: 23505561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of machine learning method and logistic regression model in prediction of acute kidney injury in severely burned patients].
    Tang CQ; Li JQ; Xu DY; Liu XB; Hou WJ; Lyu KY; Xiao SC; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2018 Jun; 34(6):343-348. PubMed ID: 29961290
    [No Abstract]   [Full Text] [Related]  

  • 37. Using Machine Learning to Predict Early Onset Acute Organ Failure in Critically Ill Intensive Care Unit Patients With Sickle Cell Disease: Retrospective Study.
    Mohammed A; Podila PSB; Davis RL; Ataga KI; Hankins JS; Kamaleswaran R
    J Med Internet Res; 2020 May; 22(5):e14693. PubMed ID: 32401216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine learning using the extreme gradient boosting (XGBoost) algorithm predicts 5-day delta of SOFA score at ICU admission in COVID-19 patients.
    Montomoli J; Romeo L; Moccia S; Bernardini M; Migliorelli L; Berardini D; Donati A; Carsetti A; Bocci MG; Wendel Garcia PD; Fumeaux T; Guerci P; Schüpbach RA; Ince C; Frontoni E; Hilty MP;
    J Intensive Med; 2021 Oct; 1(2):110-116. PubMed ID: 36785563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Characteristics and Prognostic Factors for Intensive Care Unit Admission of Patients With COVID-19: Retrospective Study Using Machine Learning and Natural Language Processing.
    Izquierdo JL; Ancochea J; ; Soriano JB
    J Med Internet Res; 2020 Oct; 22(10):e21801. PubMed ID: 33090964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification and analysis of outcome predictors in non-critically ill COVID-19 patients.
    Venturini S; Orso D; Cugini F; Crapis M; Fossati S; Callegari A; Pellis T; Tonizzo M; Grembiale A; Rosso A; Tamburrini M; D'Andrea N; Vetrugno L; Bove T
    Intern Med J; 2021 Apr; 51(4):506-514. PubMed ID: 33835685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.